Tag: Xeris Pharmaceuticals Inc (NASDAQ: XERS)

Business

Xeris Pharmaceuticals Inc (NASDAQ: XERS) Merges With Strongbridge To Form Xeris Biopharma Holdings, Inc

The stock of Xeris Pharmaceuticals Inc (NASDAQ: XERS) declined by a margin of 4.57% to eventually settle at $3.87. Xeris moves into a definitive agreement with Strongbridge, eventually taking up the company both in contingent value rights (“CVRs”) and stock.  The agreement places a price tag of about $267 million […]